Study of COYA 302 for the Treatment of ALS

Abroad (travel likely)RecruitingPHASE2

Conditions

Amyotrophic Lateral Sclerosis (ALS)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Barrow Neurological Institute, Phoenix, Arizona, United States
Contact: Study coordinator (Noelle Lemme) · Fulton.research@commonspirit.org · 602-406-6262
Cedars-Sinai Medical Center, Los Angeles, California, United States
Study coordinator · GroupneuromuscularResearch@cshs.org · (310) 423-3277
California Pacific Medical Center, San Francisco, California, United States
Contact: Study coordinator (Study Information) · clinicalresearch@sutterhealth.org · (415) 463-0379
Nova Southeastern University, Davie, Florida, United States
Contact: Study coordinator (Donovan Mott Study Coordinator) · Donovan.Mott@nova.edu · (954) 262-6387
University of Florida Clinical and Translational Research Center, Gainesville, Florida, United States
Contact: Study coordinator (Jennifer Steshyn) · Jennifer.steshyn@neurology.ufl.edu · (352) 733-2412
University Of Miami, Miami, Florida, United States
Contact: Study coordinator (Jessica Hernandez) · jph93@miami.edu · (305)243-2345
University of South Florida, Tampa, Florida, United States
Contact: Study coordinator (Jessica Shaw) · jessshaw@usf.edu · 813-974-9413
Emory University, Atlanta, Georgia, United States
Contact: Study coordinator (Katherine Terrebonne) · Katherine.cummings@emory.edu · (404)727-5193
Northwestern, Chicago, Illinois, United States
Contact: Study coordinator (Sanjana Malla) · Sanjana.malla@northwestern.edu · 312-503-4903
Johns Hopkins, Baltimore, Maryland, United States
Contact: Study coordinator (Delayna Willie) · dwillie2@jh.edu · 410-614-1196
Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Sophie Cohen) · coya302healey@mgb.org · 617-643-7828
University of Michigan, Ann Arbor, Michigan, United States
Contact: Study coordinator (Jayna Duell & Alyssa Braun) · jkballar@med.umich.edu · 734-936-8775
Washington University, St Louis, Missouri, United States
Contact: Study coordinator (Study Information-ALS Center Clinical Research) · als@wustl.edu · (314) 362-6981
Neurology Associates, P.C. Somnos Clinical Research, Lincoln, Nebraska, United States
Contact: Study coordinator (Wendy Bothe) · wendy@somnos.com · 402-770-7403
Columbia University Medical Center ALS Center, New York, New York, United States
Contact: Study coordinator (ALS Center) · alsresearch@cumc.columbia.edu · 877-426-5637
Thomas Jefferson University-Weinberg ALS Center, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Gemma Krautzel) · Gemma.krautzel@jefferson.edu · 267-582-6061
Temple Neurology, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Kathleen Hatala) · Kathleen.hatala@tuhs.temple.edu
Austin Neuromuscular Center; National Neuromuscular Research Institute, PLLC, Austin, Texas, United States
Contact: Study coordinator (Marisol Barrientos Garcia) · marisol@austinneuromuscle.com · 512-920-0140
Texas Neurology, PA, Dallas, Texas, United States
Contact: Study coordinator (Haley Rucker) · hrucker@texasneurology.com · 214-827-3610
Houston Methodist Stanley H. Appel Department of Neurology, Houston, Texas, United States
Contact: Study coordinator (Aramide Balogun) · abalogun@houstonmethodist.org · 713-441-6955
The University of Texas Health Science Center, San Antonio, Texas, United States
Contact: Study coordinator (Randee Kent-Baron) · kentbaron@uthscsa.edu · 210-450-0524
University of British Columbia, Vancouver, British Columbia, Canada
Contact: Study coordinator (Study Information) · ALSRDClinicRes@vch.ca · 604-827-2311
London Health Sciences Center, London, Ontario, Canada
Contact: Study coordinator (Study Coorinator) · denise.hulley@lhsc.on.ca · 519-661-2111
University of Toronto/Sunnybrook Health Sciences Center, Toronto, Ontario, Canada
Contact: Study coordinator (Caroline Giuricich) · alsresearch@sunnybrook.ca · 416-480-6100
Hopital Neurologique de Montreal, Montreal, Quebec, Canada
Contact: Study coordinator (Kevin Munoz) · kmunoz@gengepartners.com · 514-906-3876

View source on ClinicalTrials.gov Contact study team (email)